ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.3580
+0.0008 (0.22%)
At close: Jun 6, 2025, 4:00 PM
0.3459
-0.0121 (-3.38%)
After-hours: Jun 6, 2025, 7:57 PM EDT
ProPhase Labs Revenue
ProPhase Labs had revenue of $1.43M in the quarter ending March 31, 2025, a decrease of -39.26%. This brings the company's revenue in the last twelve months to $5.85M, down -67.59% year-over-year. In the year 2024, ProPhase Labs had annual revenue of $6.77M, down -80.65%.
Revenue (ttm)
$5.85M
Revenue Growth
-67.59%
P/S Ratio
1.51
Revenue / Employee
$60,885
Employees
96
Market Cap
14.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.77M | -28.21M | -80.65% |
Dec 31, 2023 | 34.98M | -87.66M | -71.48% |
Dec 31, 2022 | 122.65M | 43.61M | 55.17% |
Dec 31, 2021 | 79.04M | 64.53M | 444.59% |
Dec 31, 2020 | 14.51M | 4.64M | 46.96% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PRPH News
- 18 hours ago - ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform - GlobeNewsWire
- 17 days ago - ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewsWire
- 24 days ago - ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewsWire
- 2 months ago - ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - GlobeNewsWire
- 2 months ago - ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - GlobeNewsWire
- 3 months ago - ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewsWire